BACKGROUND: The role of dietary factors in non-Hodgkin lymphoma (NHL) risk is not yet well understood. Dietary flavonoids are polyphenolic compounds proposed to be anticarcinogenic. Flavonoids are well-characterized antioxidants and metal chelators, and certain flavonoids exhibit antiproliferative and antiestrogenic effects. OBJECTIVE: We aimed to evaluate the hypothesis that higher flavonoid intake is associated with lower NHL risk. DESIGN: During 1998-2000, we identified incident NHL cases aged 20-74 y from 4 US Surveillance, Epidemiology, and End Results cancer registries. Controls without history of NHL were selected by random-digit dialing or from Medicare files and frequency-matched to cases by age, center, race, and sex. Using 3 recently developed US Department of Agriculture nutrient-specific databases, flavonoid intake was estimated from participant responses to a 117-item food-frequency questionnaire (n = 466 cases and 390 controls). NHL risk in relation to flavonoid intake in quartiles was evaluated after adjustment for age, sex, registry, education, NHL family history, and energy intake. RESULTS: Higher total flavonoid intake was significantly associated with lower risk of NHL (P for trend < 0.01): a 47% lower risk in the highest quartile of intake than in the lowest (95% CI: 31%, 73%). Higher intakes of flavonols, epicatechins, anthocyanidins, and proanthocyanidins were each significantly associated with decreased NHL risk. Similar patterns of risk were observed for the major NHL subtypes--diffuse large B-cell lymphoma (n = 167) and follicular lymphoma (n = 146). CONCLUSION: A higher intake of flavonoids, dietary components with several putative anticarcinogenic activities, may be associated with lower NHL risk.
BACKGROUND: The role of dietary factors in non-Hodgkin lymphoma (NHL) risk is not yet well understood. Dietary flavonoids are polyphenolic compounds proposed to be anticarcinogenic. Flavonoids are well-characterized antioxidants and metal chelators, and certain flavonoids exhibit antiproliferative and antiestrogenic effects. OBJECTIVE: We aimed to evaluate the hypothesis that higher flavonoid intake is associated with lower NHL risk. DESIGN: During 1998-2000, we identified incident NHL cases aged 20-74 y from 4 US Surveillance, Epidemiology, and End Results cancer registries. Controls without history of NHL were selected by random-digit dialing or from Medicare files and frequency-matched to cases by age, center, race, and sex. Using 3 recently developed US Department of Agriculture nutrient-specific databases, flavonoid intake was estimated from participant responses to a 117-item food-frequency questionnaire (n = 466 cases and 390 controls). NHL risk in relation to flavonoid intake in quartiles was evaluated after adjustment for age, sex, registry, education, NHL family history, and energy intake. RESULTS: Higher total flavonoid intake was significantly associated with lower risk of NHL (P for trend < 0.01): a 47% lower risk in the highest quartile of intake than in the lowest (95% CI: 31%, 73%). Higher intakes of flavonols, epicatechins, anthocyanidins, and proanthocyanidins were each significantly associated with decreased NHL risk. Similar patterns of risk were observed for the major NHL subtypes--diffuse large B-cell lymphoma (n = 167) and follicular lymphoma (n = 146). CONCLUSION: A higher intake of flavonoids, dietary components with several putative anticarcinogenic activities, may be associated with lower NHL risk.
Authors: Amanda J Cross; Mary H Ward; Maryjean Schenk; Martin Kulldorff; Wendy Cozen; Scott Davis; Joanne S Colt; Patricia Hartge; James R Cerhan; Rashmi Sinha Journal: Carcinogenesis Date: 2005-08-19 Impact factor: 4.944
Authors: Linda E Kelemen; James R Cerhan; Unhee Lim; Scott Davis; Wendy Cozen; Maryjean Schenk; Joanne Colt; Patricia Hartge; Mary H Ward Journal: Am J Clin Nutr Date: 2006-06 Impact factor: 7.045
Authors: Min Shen; Wendy Cozen; Lan Huang; Joanne Colt; Anneclaire J De Roos; Richard K Severson; James R Cerhan; Leslie Bernstein; Lindsay M Morton; Linda Pickle; Mary H Ward Journal: Am J Epidemiol Date: 2007-11-06 Impact factor: 4.897
Authors: U Lim; M Schenk; L E Kelemen; S Davis; W Cozen; P Hartge; M H Ward; R Stolzenberg-Solomon Journal: Am J Epidemiol Date: 2005-10-12 Impact factor: 4.897
Authors: Briseis A Kilfoy; Mary H Ward; Tongzhang Zheng; Theodore R Holford; Peter Boyle; Ping Zhao; Min Dai; Brian Leaderer; Yawei Zhang Journal: Cancer Causes Control Date: 2010-03-05 Impact factor: 2.506
Authors: Mary Anne Nascimento-Souza; Pedro Gontijo de Paiva; Jara Pérez-Jiménez; Sylvia do Carmo Castro Franceschini; Andréia Queiroz Ribeiro Journal: Eur J Nutr Date: 2016-11-21 Impact factor: 5.614
Authors: Briseis Aschebrook-Kilfoy; Mary H Ward; Bhavana J Dave; Sonali M Smith; Dennis D Weisenburger; Brian C-H Chiu Journal: Leuk Lymphoma Date: 2012-10-24
Authors: Ellen T Chang; Alison J Canchola; Christina A Clarke; Yani Lu; Dee W West; Leslie Bernstein; Sophia S Wang; Pamela L Horn-Ross Journal: Cancer Causes Control Date: 2010-11-24 Impact factor: 2.506
Authors: Tait D Shanafelt; Timothy G Call; Clive S Zent; Jose F Leis; Betsy LaPlant; Deborah A Bowen; Michelle Roos; Kristina Laumann; Asish K Ghosh; Connie Lesnick; Mao-Jung Lee; Chung S Yang; Diane F Jelinek; Charles Erlichman; Neil E Kay Journal: Cancer Date: 2012-07-03 Impact factor: 6.860
Authors: Carrie A Thompson; Thomas M Habermann; Alice H Wang; Robert A Vierkant; Aaron R Folsom; Julie A Ross; James R Cerhan Journal: Int J Cancer Date: 2010-02-15 Impact factor: 7.396
Authors: Lu Wang; I-Min Lee; Shumin M Zhang; Jeffrey B Blumberg; Julie E Buring; Howard D Sesso Journal: Am J Clin Nutr Date: 2009-01-21 Impact factor: 7.045